Breaking News Instant updates and real-time market news.

PRPL

Purple

$6.53

0.1 (1.56%)

, REAL

RealReal

$16.96

-0.85 (-4.77%)

18:52
08/13/19
08/13
18:52
08/13/19
18:52

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Purple Innovation (PRPL) up 18.2%... The RealReal (REAL) up 11.8%... Grocery Outlet (GO) up 10.9%... DASAN Zhone Solutions (DZSI) up 10.6%... Change Healthcare (CHNG) up 10.2%... Huya (HUYA) up 6.7%. DOWN AFTER EARNINGS: Myriad Genetics (MYGN) down 18.1%... Reed's (REED) down 13.3%... Adaptive Biotech (ADPT) down 10.1%... Kempharm (KMPH) down 9.1%... Tilray (TLRY) down 8.0%... Personalis (PSNL) down 7.4%... CDK Global (CDK) down 7.3%... YY (YY) down 2.1%. Movers as of 18:45ET.

PRPL

Purple

$6.53

0.1 (1.56%)

REAL

RealReal

$16.96

-0.85 (-4.77%)

GO

Grocery Outlet

$37.59

0.1 (0.27%)

DZSI

Dasan Zhone

$10.52

0.63 (6.37%)

CHNG

Change Healthcare

$12.08

-0.99 (-7.57%)

HUYA

Huya

$21.31

0.91 (4.46%)

MYGN

Myriad Genetics

$44.62

-0.63 (-1.39%)

REED

Reed's

$3.02

0.045 (1.52%)

ADPT

Adaptive Biotechnologies

$43.15

1.24 (2.96%)

KMPH

KemPharm

$1.11

-0.075 (-6.33%)

TLRY

Tilray

$46.05

3.58 (8.43%)

PSNL

Personalis

$19.79

0.52 (2.70%)

CDK

CDK Global

$47.50

0.73 (1.56%)

YY

YY

$53.93

2.19 (4.23%)

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 14

    Aug

  • 19

    Aug

  • 20

    Aug

  • 05

    Sep

  • 09

    Sep

  • 12

    Sep

  • 16

    Sep

  • 18

    Sep

  • 19

    Sep

  • 01

    Oct

  • 13

    Nov

PRPL Purple
$6.53

0.1 (1.56%)

09/19/18
WEDB
09/19/18
NO CHANGE
Target $65
WEDB
Outperform
Antidumping petition could lead to relief for mattress cos, says Wedbush
A consortium of U.S. mattress manufacturers yesterday filed an antidumping duty petition with the U.S. Department of Commerce and the U.S. ITC against foam and innerspring mattresses imported from China. In a research note to investors, Wedbush analyst Seth Basham says antidumping duties over 200% could "tip the scales" back in favor of U.S. producers of low-end U.S. mattresses like Tempur Sealy's (TPX) Sealy, but says the impact for Sleep Number (SNBR) is "more limited" with no exposure to the low-mattress segment, and that Purple (PRPL) could benefit "modestly." The analyst believes that more important for Tempur Sealy is the fate of Mattress Firm (MFRM), the largest U.S. mattress retailer, which he continues to expect to file near-term for bankruptcy.
REAL RealReal
$16.96

-0.85 (-4.77%)

08/12/19
FBCO
08/12/19
NO CHANGE
Target $30
FBCO
Outperform
RealReal near-term visibility more limited, says Credit Suisse
RealReal's (REAL) near-term visibility is more limited ahead of the company's Q2 results given recent luxury read-throughs, Credit Suisse analyst Michael Binetti tells investors in a research note. Negative reads from Barney's bankruptcy and Farfetch's (FTCH) Q2 results brought RealReal's shares down 26% last week, Binetti tells investors in a research note. The analyst says the "significant compression" in digital marketplace multiples has made his $30 target price for RealReal well above the valuation of Farfetch (FTCH) and peers. However, Binetti still thinks RealReal can be a "key asset in retail stock portfolios." He believes the company has baked in some near-term revenue conservatism around the elevated industry promotions it already saw coming ahead of the initial public offering. Further, the analyst notes that in past periods of increased promos in the primary luxury space, RealReal has seen "unexpected positive lifts" to its new customer growth trends. Binetti keeps an Outperform rating on the shares.
07/23/19
KEYB
07/23/19
INITIATION
Target $31
KEYB
Overweight
RealReal initiated with an Overweight at KeyBanc
KeyBanc analyst Edward Yruma started coverage of RealReal with an Overweight rating and a $31 price target. The analyst believes RealReal is driving "real innovation" at the nexus of the circular economy, luxury, and e-commerce, and has "strong competitive advantages," particularly in supply, that differentiate it from peers. Further, Yruma thinks it can sustain 25%-plus Gross Merchandise Volume growth and attain profitability by 2021/2022.
07/23/19
BOFA
07/23/19
INITIATION
Target $28
BOFA
Neutral
RealReal initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated RealReal with a Neutral and $28 price target.
07/23/19
COWN
07/23/19
INITIATION
Target $32
COWN
Outperform
RealReal initiated with an Outperform at Cowen
Cowen analyst Oliver Chen initiated RealReal with an Outperform rating as he believes its customer-centric supply gathering infrastructure, rapid turnover single SKU management and authentication will drive customer trust and engagement. He sees the company profitable by 2022. Chen has a $32 price target on RealReal shares.
GO Grocery Outlet
$37.59

0.1 (0.27%)

07/15/19
MSCO
07/15/19
INITIATION
Target $30
MSCO
Equal Weight
Grocery Outlet initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Simeon Gutman initiated Grocery Outlet with an Equal Weight rating and $30 price target, stating that while he views it as a core holding for long-term investors given its long runway growth in a defensive industry, the stock appears to be pricing in more EBITDA growth than he forecasts in the nearer-term.
07/15/19
COWN
07/15/19
INITIATION
Target $42
COWN
Outperform
Grocery Outlet initiated with an Outperform at Cowen
Cowen analyst Oliver Chen initiated Grocery Outlet with an Outperform as its agile off-price buying execution drives a strong value proposition and share gains leading to mid-teens net income growth. Chen has a $42 price target on Grocery Outlet shares.
07/15/19
07/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) initiated with an Outperform at William Blair, an Overweight at Barclays, and a Buy at Canaccord. 2. Grocery Outlet (GO) initiated with an Outperform at Telsey Advisory and Cowen, a Buy at Jefferies, an Equal Weight at Morgan Stanley, as well as a Neutral at Goldman Sachs, BofA/Merrill, and Guggenheim. 3. Atreca (BCEL) initiated with an Outperform at Evercore ISI and Cowen, as well as a Buy at Stifel. 4. Aqua America (WTR) initiated with a Buy at BofA/Merrill. 5. Anaplan (PLAN) initiated with an Outperform at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/15/19
GUGG
07/15/19
INITIATION
GUGG
Neutral
Grocery Outlet initiated with a Neutral at Guggenheim
Prior to the open, Guggenheim analyst John Heinbockel initiated Grocery Outlet with a Neutral rating, stating that he believes the company is well positioned for 5-10 years of sales growth greater than 10% and deserves a premium valuation. However, with the shares up 55% since the IPO, he thinks the growth potential is reflected in the current valuation.
DZSI Dasan Zhone
$10.52

0.63 (6.37%)

07/09/19
RILY
07/09/19
NO CHANGE
RILY
B. Riley FBR says China supply chain internalization issue for optical industry
B. Riley FBR analyst Dave Kang lowered his price target for Lumentum (LITE) to $68 from $74 and for Inphi (IPHI) to $45 from $47. While the ban on Huawei has garnered investor attention recently, the bigger issue for the optical industry could be China's internalization of its supply chain, which has been accelerated due to the recent ban, Kang tells investors in a research note. The analyst believes that even after the partial reprieve on Huawei, the U.S. optical companies may not fully recover to the previous levels with Huawei. Recent channel checks revealed that Huawei has significantly accelerated the internalization process of its supply chain, adds the analyst. As a result, he believes the U.S. optical industry is facing "collateral damage" from the trade war with China. Kang keeps a Buy rating on Lumentum and Neutral rating on Inphi. He favors Huawei's competitors such as Ciena (CIEN) and Dasan Zhone Solutions (DZSI), which he believes could gain market share from international customers diversifying away from Huawei.
05/20/19
RILY
05/20/19
INITIATION
Target $19.5
RILY
Buy
Dasan Zhone initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Dave Kang started Dasan Zhone Solutions with a Buy rating and $19.50 price target. The company is outpacing the broadband industry through share gains, Kang tells investors in a research note.
CHNG Change Healthcare
$12.08

-0.99 (-7.57%)

07/22/19
07/22/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BridgeBio (BBIO) initiated with an Overweight at JPMorgan and Piper Jaffray, an Outperform at SVB Leerink and BMO Capital, and a Buy at Jefferies and Goldman Sachs. 2. Uber (UBER) initiated with a Hold at HSBC. 3. Change Healthcare (CHNG) initiated with an Outperform at William Blair, Credit Suisse, Cowen, and SVB Leerink, an Overweight at JPMorgan, Cantor Fitzgerald, Barclays, and Piper Jaffray, a Buy at SunTrust, Guggenheim, BofA/Merrill, Citi, and Goldman Sachs, and a Market Perform at Wells Fargo. 4. AMD (AMD) initiated with a Neutral at Atlantic Equities. 5. Medallia (MDLA) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/19
RHCO
07/22/19
INITIATION
Target $21
RHCO
Buy
Change Healthcare initiated with a Buy at SunTrust
SunTrust analyst Sandy Draper initiated Change Healthcare with a Buy rating and a price target of $21. The analyst says the market views the company as a "low growth, highly levered,complicated story", but believes that inflection points are coming over the next 12-24 months given that its $100B total addressable market is growing by up to 5%. Draper also cites Change Healthcare's high recurring revenue and low customer concentration since no single customer accounted for over 4% of total revenue in FY19.
07/22/19
WBLR
07/22/19
INITIATION
WBLR
Outperform
Change Healthcare initiated with an Outperform at William Blair
William Blair analyst Ryan Daniels started Change Healthcare with an Outperform rating saying the company is well positioned to remain a leader in the healthcare information technology space. Change Healthcare is a "mission-critical" partner for both payers and providers, with a fully integrated solution set that is "deeply engrained" in client workflows, Daniels tells investors in a research note.
07/22/19
FBCO
07/22/19
INITIATION
Target $18
FBCO
Outperform
Change Healthcare initiated with an Outperform at Credit Suisse
Credit Suisse analyst Jailendra Singh started coverage of Change Healthcare with an Outperform rating and $18 price target. The analyst believes the company should benefit from favorable system-wide trends, including reducing unnecessary medical spend, a growing population of chronically ill and higher-risk patients, increasing adoption of value-based care models, increasing consumerism of healthcare services, and proliferation of healthcare data.
HUYA Huya
$21.31

0.91 (4.46%)

08/05/19
JEFF
08/05/19
INITIATION
Target $26.8
JEFF
Buy
Huya initiated with a Buy at Jefferies
Jefferies analyst Thomas Chong started Huya with a Buy rating and $26.80 price target. The analyst expects Huya to "ride on the increasing popularity" of e-Sports in China with "fast" revenue growth amid the early stages of game broadcasting monetization in China.
07/02/19
EGHT
07/02/19
UPGRADE
EGHT
Buy
Huya upgraded to Buy from Hold at 86 Research
07/09/19
LYON
07/09/19
DOWNGRADE
LYON
Outperform
Huya downgraded to Outperform from Buy at CLSA
07/08/19
DAIW
07/08/19
UPGRADE
Target $30
DAIW
Outperform
Huya upgraded to Outperform from Neutral at Daiwa
Daiwa analyst Carlton Lai upgraded Huya to Outperform from Neutral and raised his price target for the shares to $30 from $27.
MYGN Myriad Genetics
$44.62

-0.63 (-1.39%)

08/01/19
LEHM
08/01/19
UPGRADE
Target $40
LEHM
Equal Weight
Myriad Genetics upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Jack Meehan upgraded Myriad Genetics (MYGN) to Equal Weight from Underweight and raised his price target for the shares to $40 from $18 following this morning's positive coverage decision by UnitedHealth (UNH).
08/02/19
BOFA
08/02/19
UPGRADE
BOFA
Neutral
Myriad Genetics upgraded to Neutral from Underperform at BofA/Merrill
08/01/19
COWN
08/01/19
NO CHANGE
COWN
Cowen sees upside for Myriad after UnitedHealth decision
Cowen analyst Doug Schenkel, who maintained a Market Perform rating and $30 price target on Myriad (MYGN), noted that Myriad announced that UnitedHealth (UNH) had issued a positive coverage decision for GeneSight, effective October 1, that does not have any provider restrictions. With a reimbursement rate of $2,000, Schenkel sees the potential for $50M-$75M of upside to his FY20 revenue forecast for Myriad.
08/02/19
BOFA
08/02/19
UPGRADE
Target $46
BOFA
Neutral
BofA/Merrill upgrades Myriad to Neutral on unexpected UnitedHealthcare decision
BofA/Merrill analyst Derik de Bruin upgraded Myriad Genetics to Neutral from Underperform and raised his price target for the shares to $46 from $28. UnitedHealthcare (UNH) unexpectedly changed its coverage rationale regarding the use of pharmacogenetics tests to guide treatment decisions and will now start reimbursing Myriad's GeneSight Psychotropic test, de Bruin tells investors in a research note. Further, there are also no provider restrictions on which physicians can order GeneSight Psychotropic, adds the analyst, who says Myriad can now launch its sales force and push tests into the primary care market.
REED Reed's
$3.02

0.045 (1.52%)

05/10/19
05/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wayfair (W) initiated with a Sell at Berenberg. 2. United Technologies (UTX) initiated with a Neutral at Seaport Global. 3. Alcon (ALC) initiated with an Outperform at Baird. 4. Pinterest (PINS) initiated with a Buy at Nomura Instinet and a Hold at Argus. 5. Reed's (REED) initiated with a Buy at RF Lafferty. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/10/19
RFLF
05/10/19
INITIATION
Target $5
RFLF
Buy
Reed's initiated with a Buy at RF Lafferty
RF Lafferty analyst Roger Duan started Reed's with a Buy rating and $5 price target, citing the company's accelerating growth under new management, its leading position in craft beverages and its launch of several new products, including some with CBD.
04/26/19
04/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Vail Resorts (MTN) initiated with a Buy at SunTrust. 2. Tocagen (TOCA) initiated with an Overweight at Cantor Fitzgerald. 3. Dow Inc. (DOW) initiated with a Hold at Argus. 4. Gilead (GILD) initiated with an Outperform at Bernstein. 5. Reed's (REED) initiated with a Buy at Lake Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/19
LSCM
04/26/19
INITIATION
Target $6
LSCM
Buy
Reed's initiated with a Buy at Lake Street
Lake Street analyst Chris Krueger started Reed's with a Buy rating and $6 price target. The analyst believes the company is well positioned to take advantage of the "healthy consumer trend with its unique, handcrafted beverage products." Reed's will return to growth mode in 2019, with increasing margins, Krueger tells investors in a research note. He believes the company can grow sales annually at 20% for the next several years and could eventually become a takeout candidate for a larger beverage company. The stock should move higher as Reed's is awarded a growth multiple and revenues accelerate, contends Krueger.
ADPT Adaptive Biotechnologies
$43.15

1.24 (2.96%)

07/22/19
GUGG
07/22/19
INITIATION
Target $47
GUGG
Buy
Adaptive Biotechnologies initiated with a Buy at Guggenheim
Guggenheim analyst David Westenberg initiated Adaptive Biotechnologies with a Buy and $47 price target.
07/23/19
07/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Buy at Rosenblatt, while Twitter (TWTR) was initiated with a Neutral. 2. Silicon Labs (SLAB) initiated with a Buy at Benchmark, while Intel (INTC) and Xilinx (XLNX) were initiated with Hold ratings. 3. Cambridge Bancorp (CATC) initiated with a Market Perform at Keefe Bruyette. 4. Broadcom (AVGO) assumed with an Outperform at RBC Capital. 5. Adaptive Biotechnologies (ADPT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/19
WBLR
07/22/19
INITIATION
WBLR
Outperform
Adaptive Biotechnologies initiated with an Outperform at William Blair
William Blair analyst Brian Weinstein started Adaptive Biotechnologies with an Outperform rating saying the company's technology holds the promise to enable researchers, commercial partners, and ultimately clinicians to better diagnose and treat disease. The analyst sees potential for upside to revenue targets.
07/23/19
BTIG
07/23/19
INITIATION
Target $46
BTIG
Buy
Adaptive Biotechnologies initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Adaptive Biotechnologies (ADPT) with a Buy rating and a price target of $46, saying the company's "clinical immunomics database" represents its "differentiating asset" and offers "incredible value" to biopharma companies. The analyst further cites Adaptive Biotechnologies' partnership with Roche (RHHBY) that should allow it to develop new diagnostics for early detection of diseases where antigens are unknown and also its "strategic" deal with Microsoft (MSFT), whose machine learning capabilities support its immune medicine platform.
KMPH KemPharm
$1.11

-0.075 (-6.33%)

06/19/19
06/19/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Fiserv (FISV) initiated with an Outperform at Wells Fargo. 2. KemPharm (KMPH) initiated with a Buy at H.C. Wainwright. 3. Marvell (MRVL) initiated with a Market Perform at Raymond James. 4. Citizens Financial (CFG) initiated with a Hold at Argus. 5. Boot Barn (BOOT) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/18
OPCO
09/20/18
INITIATION
OPCO
Outperform
KemPharm assumed with an Outperform at Oppenheimer
Oppenheimer analyst Esther Rajavelu assumed coverage of KemPharm with an Outperform rating and an $11 price target, primarily due to a change in the firm's valuation methodology.
05/23/19
OPCO
05/23/19
NO CHANGE
Target $3
OPCO
Outperform
KemPharm price target lowered to $3 from $8 at Oppenheimer
Oppenheimer analyst Esther Rajavelu lowered her price target for KemPharm to $3 from $8 to incorporate Q1 results and given a higher discount rate of 11.7% and a lower probability of timely approval for KP415/KP484 of 50%. The analyst reiterates an Outperform rating on the shares.
06/19/19
HCWC
06/19/19
INITIATION
Target $3
HCWC
Buy
KemPharm initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat started KemPharm with a Buy rating and $3 price target. KemPharm's lead assets are KP415, a prodrug of methylphenidate designed to have best-in-class onset and duration and lower abusability, and Apadaz, a prodrug of hydrocodone designed to be a less abusable Vicodin, Livnat tells investors in a research note. The analyst believes believe both products could ultimately prove more differentiated and successful than investors believe.
TLRY Tilray
$46.05

3.58 (8.43%)

06/28/19
CEDG
06/28/19
INITIATION
Target $54
CEDG
Overweight
Tilray initiated with an Overweight at Consumer Edge
Consumer Edge initiated Tilray with an Overweight and $54 price target.
06/26/19
VERF
06/26/19
NO CHANGE
VERF
Sell
Canadian cannabis earnings could disappoint in Q2, says Vertical Group
Vertical Group analyst Gordon Johnson, who maintains a Sell rating on Tilray (TLRY), said in an emailed note that Health Canada provided statistics for April yesterday that shed light on the supply/demand backdrop in the Canadian cannabis market. Sell-in growth slowed from 11.5% month-over-month in March to 9.7% month-over-month in April and sell-through "collapsed" 39.4% month-over-month following a large increase in March, according to Johnson. He concludes from the data that end-demand is collapsing while inventory across all categories continues to bulge, which suggests to him that Canadian cannabis earnings "could be setting up for yet another disappointment" in Q2. Other publicly traded Canadian cannabis producers include Canopy Growth (CGC) and Aurora Cannabis (ACB).
06/17/19
COMP
06/17/19
NO CHANGE
Target $38
COMP
Neutral
Tilray price target lowered to $38 on Canadian regulatory delay at Compass Point
Compass Point analyst Rommel Dionisio lowered his revenue and earnings estimates for Tilray and cut his price target on the shares to $38 from $41 after the Canadian government issued a press release Friday that he said effectively delays the introduction of advanced forms of cannabis until at least mid-December 2019, at the earliest. Licensed cannabis companies must give Health Canada 60-days notice of their intent to sell products such as vapes, beverages, or edibles, but the government will not be accepting any such applications until Oct. 17, noted Dionisio, who keeps a Neutral rating on Tilray shares.
07/17/19
LTCO
07/17/19
INITIATION
LTCO
Neutral
Tilray initiated with a Neutral at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Tilray with a Neutral rating. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." A significant portion of Tilray's near-term growth is a result of its Manitoba acquisition, which is mainly an organic foods company, as opposed to growth from cannabis, Mattson tells investors in a research note.
PSNL Personalis
$19.79

0.52 (2.70%)

07/15/19
MSCO
07/15/19
INITIATION
Target $28
MSCO
Overweight
Personalis initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lewis initiated Personalis with an Overweight rating and $28 price target, citing his view that the company's NeXT platform is positioned to gain share as the oncology market moves toward targeted therapies. Additionally, Personalis does not have direct reimbursement risk as do peers that potentially have exposure via companion diagnostics, Lewis tells investors.
07/15/19
BOFA
07/15/19
INITIATION
Target $27
BOFA
Neutral
Personalis initiated with a Neutral at BofA/Merrill
BofA Merrill Lynch analyst Derik de Bruin initiated Personalis with a Neutral rating and $27 price target. While he thinks the company will benefit from the growing need for more genomic data in immune-oncology and cancer drug development, he also believes that shares are fairly valued given the early stage of the business and limited visibility, de Bruin tells investors.
07/15/19
COWN
07/15/19
INITIATION
COWN
Outperform
Personalis initiated with an Outperform at Cowen
Cowen analyst Doug Schenkel initiated Personalis with an Outperform as he sees it as an emerging biopharma partner to aid in the development of high growth IO programs, including bespoke therapies.
07/15/19
OPCO
07/15/19
INITIATION
Target $29
OPCO
Outperform
Personalis initiated with an Outperform at Oppenheimer
Oppenheimer analyst Kevin DeGeeter started coverage of Personalis with an Outperform rating and $29 price target. The analyst views it as well positioned to benefit from secular growth trends in oncology drug development and expects the company to solidify its position as a preferred provider of genetic testing services to pharmaceutical clients, based on channel checks suggesting a high level of customer support, maturing landscape requiring more complex diagnostic testing, and upside from clinical trials of personalized neoantigen products.
CDK CDK Global
$47.50

0.73 (1.56%)

07/01/19
BRRR
07/01/19
NO CHANGE
Target $80
BRRR
Outperform
CDK Global divestiture 'very positive' for shareholder value, says Barrington
Barrington analyst Gary Prestopino believes CDK Global's plan divest its digital marketing businesses is "very positive" for long-term shareholder value. These businesses were "cyclical, competitive, overly reliant on one client and not positively impacting shareholder value," Prestopino tells investors in a research note. The analyst keeps an Outperform rating on CDK Global with an $80 price target.
11/08/18
11/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) downgraded to Neutral from Positive at Susquehanna analyst James Friedman citing valuation and the lack of a CFO at the company. 2. Landstar System (LSTR) downgraded to Neutral from Buy at Goldman Sachs and to Sector Weight from Overweight at KeyBanc. 3. Dean Foods (DF) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale saying he believes the company's cost savings opportunity is significant enough to more than offset secular headwinds. 4. Ctrip (CTRP) downgraded to Neutral from Outperform at Credit Suisse, to Neutral from Buy at Citi, to Underperform from Outperform at CLSA, and to Hold from Buy at China Renaissance. 5. CDK Global (CDK) downgraded to Market Perform from Outperform at Wells Fargo with analyst Timothy Willi saying he believes that CDK faces a variety of headwinds during FY19 that will likely limit upside in the shares despite the discounted valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/18
BRRR
11/13/18
NO CHANGE
Target $80
BRRR
Outperform
CDK Global post-earnings pullback unwarranted, says Barrington
Barrington analyst Gary Prestopino said CDK Global's Q1 results were better than his expectations and he believes the decline of over 12% in the shares since the report is unwarranted and has created a significant buying opportunity. He also notes the company's guidance reduction was due to its inclusion of ELEAD1ONE, the deal for which recently closed and will be dilutive to FY19 results. Prestopino maintains an Outperform rating on CDK shares with an $80 price target.
01/30/19
MSCO
01/30/19
NO CHANGE
Target $57
MSCO
Equal Weight
Morgan Stanley skeptical of CDK reports on Cars.com bid, GM loss
Morgan Stanley analyst Brian Essex says he remains skeptical of reports that CDK Global (CDK) may make a takeover bid for Cars.com (CARS). Several previous reports had CDK involved in a transaction that never materialized, Essex tells investors in an intraday research note. The analyst says that while a deal with Cars.com could make strategic sense, he would need to see compelling valuation, evidence of fundamental improvement, and synergy dynamics "in order for it to make sense." He's also skeptical of news regarding the loss of General Motors (GM), CDK Global's largest customer. CDK has highlighted on its past few earnings calls revenue declines associated with a pullback in advertising spending at GM, "but we understand they remain a substantial customer of CDK," Essex writes. He keeps an Equal Weight rating on CDK Global with a $57 price target. The stock in afternoon trading is down 5%, or $2.78, to $48.46. Cars.com, on the other hand, is up 5%, or $1.22, to $27.24.
YY YY
$53.93

2.19 (4.23%)

05/29/19
05/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Flex (FLEX) upgraded to Overweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 2. Allstate (ALL) and Hartford Financial (HIG) were upgraded to Buy from Neutral at Goldman Sachs. 3. Rockwell Automation (ROK) upgraded to Buy from Hold at Gabelli with analyst Justin Bergner saying the negative investor sentiment stemming from "skepticism" of its software partnership strategy and the decline in the relevance of its programmable logic controller is unwarranted. 4. Falcon Minerals (FLMN) upgraded to Buy from Hold at Stifel with analyst Timothy Howard saying Falcon shares have underperformed over the last 30 days, falling 17% compared to peers down 6% and crude oil prices down 7%. 5. YY (YY) upgraded to Buy from Neutral at Nomura Instinet with t analyst Jialong Shi saying the risk/reward is more favorable with the stock down 27% from its recent peak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/05/19
JEFF
08/05/19
INITIATION
Target $76.1
JEFF
Buy
YY initiated with a Buy at Jefferies
Jefferies analyst Thomas Chong initiated YY with a Buy rating and $76.10 price target, noting that it is one of the few internet companies in China stepping up overseas expansion in 2019, which he views as a positive for long-term growth. He also notes that YY's product portfolio has "a huge user base" of over 400M users with solid growth across different applications.
07/15/19
NOMU
07/15/19
NO CHANGE
Target $79
NOMU
Buy
YY target raised to $79 ahead of Q2 results at Nomura Instinet
Nomura Instinet analyst Jialong Shi raised his price target for YY to $79 from $77 ahead of the company's Q2 results and keeps a Buy rating on the shares. The analyst forecasts YY's consolidated revenue in Q2 will grow 64% year-over-year and 1% above consensus on the back of the strong growth in Huya and a full quarter consolidation of Bigo.
05/29/19
NOMU
05/29/19
UPGRADE
Target $77
NOMU
Buy
Nomura Instinet upgrades YY to Buy after 27% correction
Nomura Instinet analyst Jialong Shi upgraded YY (YY) to Buy from Neutral while lowering his price target for the shares to $77 from $81. The risk/reward is more favorable with the stock down 27% from its recent peak, Shi tells investors in a research note. The analyst thinks the current market volatility, triggered by macro concerns, may benefit "cheap stocks with macro-defensive businesses" such as YY and Momo (MOMO).

TODAY'S FREE FLY STORIES

LGF.B

Lionsgate

$9.84

-0.375 (-3.67%)

, LGF.A

Lionsgate

$10.37

-0.43 (-3.98%)

19:38
08/25/19
08/25
19:38
08/25/19
19:38
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

LGF.B

Lionsgate

$9.84

-0.375 (-3.67%)

LGF.A

Lionsgate

$10.37

-0.43 (-3.98%)

ROKU

Roku

$137.77

-1.35 (-0.97%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

NFLX

Netflix

$291.40

-5.47 (-1.84%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

TGT

Target

$103.64

-2.62 (-2.47%)

DIS

Disney

$131.70

-4.37 (-3.21%)

NSRGY

Nestle

$0.00

(0.00%)

ULTA

Ulta Beauty

$322.34

-12.5 (-3.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 29

    Aug

  • 04

    Sep

  • 05

    Sep

  • 15

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 27

    Oct

T

AT&T

$34.82

-0.57 (-1.61%)

, CMCSA

Comcast

$42.47

-1.29 (-2.95%)

18:38
08/25/19
08/25
18:38
08/25/19
18:38
On The Fly
Box Office Battle: 'Angel has Fallen' wins weekend with $21.3M debut »

"Box Office Battle" is…

T

AT&T

$34.82

-0.57 (-1.61%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$53.75

-1.03 (-1.88%)

LGF.A

Lionsgate

$10.37

-0.43 (-3.98%)

LGF.B

Lionsgate

$9.84

-0.375 (-3.67%)

DIS

Disney

$131.70

-4.37 (-3.21%)

VIAB

Viacom

$24.65

-1.21 (-4.68%)

VIA

Viacom

$26.85

-0.74 (-2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 23

    Oct

  • 27

    Oct

FB

Facebook

$177.69

-4.39 (-2.41%)

17:23
08/25/19
08/25
17:23
08/25/19
17:23
Periodicals
U.S. lawmaker still concerned about Facebook cryptocurrency, Reuters reports »

The chair of the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

FCX

Freeport McMoRan

$8.84

-0.295 (-3.23%)

, BHP

BHP Group

$46.72

-0.52 (-1.10%)

17:11
08/25/19
08/25
17:11
08/25/19
17:11
Periodicals
China to raise tariffs on U.S. scrap copper, aluminum from Dec. 15, Reuters says »

China will impose an…

FCX

Freeport McMoRan

$8.84

-0.295 (-3.23%)

BHP

BHP Group

$46.72

-0.52 (-1.10%)

SCCO

Southern Copper

$29.56

-0.61 (-2.02%)

RIO

Rio Tinto

$47.99

-0.56 (-1.15%)

AA

Alcoa

$17.47

-0.57 (-3.16%)

ARNC

Arconic

$24.32

-0.77 (-3.07%)

KALU

Kaiser Aluminum

$86.11

-3.97 (-4.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 16

    Oct

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

, SPX

S&P 500

$0.00

(0.00%)

17:01
08/25/19
08/25
17:01
08/25/19
17:01
Periodicals
China warns of consequences if U.S. continues 'wrong actions,' Reuters says »

China said it strongly…

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$211.38

-10.69 (-4.81%)

16:51
08/25/19
08/25
16:51
08/25/19
16:51
Periodicals
Tesla scouting sites for possible factory in Germany, Reuters reports »

Tesla is scouting out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

ESLOY

EssilorLuxottica

$0.00

(0.00%)

, NSRGY

Nestle

$0.00

(0.00%)

16:48
08/25/19
08/25
16:48
08/25/19
16:48
Periodicals
Third Point builds stake in EssilorLuxottica, Reuters reports »

Third Point, the U.S.…

ESLOY

EssilorLuxottica

$0.00

(0.00%)

NSRGY

Nestle

$0.00

(0.00%)

CPB

Campbell Soup

$42.66

-1.01 (-2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 01

    Oct

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

, SPX

S&P 500

$0.00

(0.00%)

16:41
08/25/19
08/25
16:41
08/25/19
16:41
Periodicals
Trump adviser not expecting China to retaliated against latest tariffs, Reuters »

White House economic…

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

, SPX

S&P 500

$0.00

(0.00%)

16:33
08/25/19
08/25
16:33
08/25/19
16:33
Periodicals
Leaders says U.S., Japan have agreed in principle on trade deal, Reuters says »

The U.S. and Japan agreed…

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

, SPX

S&P 500

$0.00

(0.00%)

16:30
08/25/19
08/25
16:30
08/25/19
16:30
Periodicals
Trump regrets not raising tariffs on China higher, Reuters reports »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$131.70

-4.37 (-3.21%)

, TGT

Target

$103.64

-2.62 (-2.47%)

16:16
08/25/19
08/25
16:16
08/25/19
16:16
Hot Stocks
Disney, Target team up to bring Disney store to retailer shoppers »

Disney (DIS) and Target…

DIS

Disney

$131.70

-4.37 (-3.21%)

TGT

Target

$103.64

-2.62 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

SEDG

SolarEdge

$80.96

-1.14 (-1.39%)

16:11
08/25/19
08/25
16:11
08/25/19
16:11
Hot Stocks
SolarEdge announces death of co-chairman, founder Guy Sella »

SolarEdge Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/25/19
08/25
04:55
08/25/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

NFLX

Netflix

$291.40

-5.47 (-1.84%)

, DIS

Disney

$131.70

-4.37 (-3.21%)

11:55
08/24/19
08/24
11:55
08/24/19
11:55
Periodicals
Football season is back, key moment for TV future, Barron's says »

On Sept. 5, when the…

NFLX

Netflix

$291.40

-5.47 (-1.84%)

DIS

Disney

$131.70

-4.37 (-3.21%)

FOXA

Fox Corp.

$31.76

-1.29 (-3.90%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CBS

CBS

$41.39

-2.06 (-4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

AAPL

Apple

$202.73

-9.82 (-4.62%)

, AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

09:03
08/24/19
08/24
09:03
08/24/19
09:03
Periodicals
Costco the most 'woke' company out there, Barron's says »

Earlier this week, the…

AAPL

Apple

$202.73

-9.82 (-4.62%)

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

BLK

BlackRock

$407.29

-11.55 (-2.76%)

WMT

Walmart

$110.83

-1.07 (-0.96%)

COST

Costco

$274.16

-5.7 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 03

    Oct

  • 27

    Oct

  • 13

    Nov

  • 14

    Nov

MMM

3M

$155.84

-5.04 (-3.13%)

08:58
08/24/19
08/24
08:58
08/24/19
08:58
Periodicals
3M stock still not looking like a bargain, Barron's says »

3M shares are down by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ULTA

Ulta Beauty

$322.34

-12.5 (-3.73%)

08:56
08/24/19
08/24
08:56
08/24/19
08:56
Periodicals
Ulta Beauty bucking downbeat retail trends, Barron's says »

Ulta Beauty has been one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 25

    Sep

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$42.47

-1.29 (-2.95%)

08:49
08/24/19
08/24
08:49
08/24/19
08:49
Periodicals
Roku working for investors, Barron's says »

The streaming war…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

DIS

Disney

$131.70

-4.37 (-3.21%)

NFLX

Netflix

$291.40

-5.47 (-1.84%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

ROKU

Roku

$137.77

-1.35 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

NSRGY

Nestle

$0.00

(0.00%)

08:44
08/24/19
08/24
08:44
08/24/19
08:44
Periodicals
Nestle stock looking appetizing after big gain, Barron's says »

Nestle is having a great…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$291.40

-5.47 (-1.84%)

, DIS

Disney

$131.70

-4.37 (-3.21%)

08:39
08/24/19
08/24
08:39
08/24/19
08:39
Periodicals
Football season is back, key moment for TV future, Barron's says »

On Sept. 5, when the…

NFLX

Netflix

$291.40

-5.47 (-1.84%)

DIS

Disney

$131.70

-4.37 (-3.21%)

FOXA

Fox Corp.

$31.76

-1.29 (-3.90%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CBS

CBS

$41.39

-2.06 (-4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

, FDX

FedEx

$151.94

-6.17 (-3.90%)

08:05
08/24/19
08/24
08:05
08/24/19
08:05
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

FDX

FedEx

$151.94

-6.17 (-3.90%)

UPS

UPS

$111.29

-3.91 (-3.39%)

F

Ford

$8.76

-0.27 (-2.99%)

GM

General Motors

$36.06

-1.19 (-3.19%)

DDAIF

Daimler AG

$0.00

(0.00%)

HMC

Honda

$22.90

-0.32 (-1.38%)

TM

Toyota

$127.94

-1.69 (-1.30%)

VWAGY

Volkswagen

$0.00

(0.00%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

FB

Facebook

$177.69

-4.39 (-2.41%)

TWTR

Twitter

$41.01

-1.16 (-2.75%)

GOOGL

Alphabet Class A

$1,154.66

-35.75 (-3.00%)

GOOG

Alphabet

$1,151.72

-36.81 (-3.10%)

ADM

Archer Daniels

$37.44

-0.48 (-1.27%)

REGI

Renewable Energy

$11.65

0.61 (5.53%)

GPRE

Green Plains

$7.34

-0.68 (-8.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 17

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 13

    Nov

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/24/19
08/24
04:55
08/24/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.